Next Article in Journal
Efficacy and Tolerability of Toremifene and Tamoxifen Therapy in Premenopausal Patients with Operable Breast Cancer: A Retrospective Analysis
Previous Article in Journal
Do We Need Another Selective Estrogen Receptor Modulator for the Adjuvant Treatment of Breast Cancer?
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

hpv is Here to Stay

S-3, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada
Curr. Oncol. 2013, 20(4), 194-195; https://doi.org/10.3747/co.20.1569
Submission received: 5 May 2013 / Revised: 8 June 2013 / Accepted: 10 July 2013 / Published: 1 August 2013

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Human papillomavirus (HPV) was first detected in head-and-neck cancers in the 1980s1.[...]

Share and Cite

MDPI and ACS Style

Corsten, M. hpv is Here to Stay. Curr. Oncol. 2013, 20, 194-195. https://doi.org/10.3747/co.20.1569

AMA Style

Corsten M. hpv is Here to Stay. Current Oncology. 2013; 20(4):194-195. https://doi.org/10.3747/co.20.1569

Chicago/Turabian Style

Corsten, Martin. 2013. "hpv is Here to Stay" Current Oncology 20, no. 4: 194-195. https://doi.org/10.3747/co.20.1569

APA Style

Corsten, M. (2013). hpv is Here to Stay. Current Oncology, 20(4), 194-195. https://doi.org/10.3747/co.20.1569

Article Metrics

Back to TopTop